Biogen.ca - Home | Biogen

Provided by Alexa ranking, biogen.ca has ranked N/A in N/A and 6,074,840 on the world. biogen.ca reaches roughly 508 users per day and delivers about 15,246 users each month. The domain biogen.ca uses a Commercial suffix and it's server(s) are located in N/A with the IP number 3.219.125.195 and it is a .ca domain.

WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …

List of domain same IP 3.219.125.195

Keywords on this domain

biogen

Search Results related to biogen.ca on Search Engine

Home | Biogen
biogen.com

https://www.biogen.com/

WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …

DA: 38 PA: 49 MOZ Rank: 61

Company | Biogen
biogen.com

https://www.biogen.com/company.html

WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …

DA: 92 PA: 70 MOZ Rank: 52

Biogen - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Biogen

WEBBiogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...

DA: 87 PA: 74 MOZ Rank: 12

Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/BIIB/

WEB41.11. +0.49%. Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.

DA: 13 PA: 21 MOZ Rank: 89

Pipeline | Biogen
biogen.com

https://www.biogen.com/science-and-innovation/pipeline.html

WEBBreaking New Ground With Science. With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.

DA: 62 PA: 32 MOZ Rank: 53

News | Biogen
biogen.com

https://investors.biogen.com/news/news-releases

WEBMay 7, 2018 · Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression. January 29, 2023. News Release.

DA: 68 PA: 73 MOZ Rank: 66

Science & Innovation | Biogen
biogen.com

https://www.biogen.com/science-and-innovation.html

WEBThe potential to transform the lives of patients is what drives us at Biogen. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.

DA: 79 PA: 2 MOZ Rank: 52

FDA Approves Biogen’s Drug for Rare Form of ALS - The New York Times
nytimes.com

https://www.nytimes.com/2023/04/25/business/biogen-fda-als-drug.html

WEBBy Rebecca Robbins. April 25, 2023. The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic form of the neurological disorder A.L.S., despite uncertainty about the...

DA: 34 PA: 52 MOZ Rank: 64

Biogen to Present New Data at the Clinical Trials on Alzheimer’s
biogen.com

https://investors.biogen.com/news-releases/news-release-details/biogen-present-new-data-clinical-trials-alzheimers-disease-ctad

WEBOctober 19, 2023 • News Release. Late-breaking Phase 1b data assesses the clinical outcomes of reducing tau in patients with early-stage Alzheimer’s disease. Additional late-breaking presentations from the CLARITY AD study explore predictive biomarkers and novel subcutaneous administration of LEQEMBI ® (lecanemab-irmb)

DA: 45 PA: 70 MOZ Rank: 66

About Biogen
biogencsr.com

https://www.biogencsr.com/en_us/about-biogen.html

WEBAbout Biogen. At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by ...

DA: 4 PA: 59 MOZ Rank: 34

Alexa Rank

GLOBAL RANK

6,074,840

Alexa Reach

0.0000224337

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

508

Monthly Unique Visitors

15,246

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

3,261

Indonesia

2,551

Taiwan

829

United Kingdom

736

Brazil

666

Nigeria

582

Egypt

489

Hong Kong

462

Canada

462

Australia

402

Philippines

288

India

281

Malaysia

276

Spain

229

Germany

223

Mexico

213

France

201

Italy

186

Turkey

171

Iraq

156

Thailand

152

Netherlands

146

Israel

145

Cambodia

120

Algeria

Ireland

Romania

Jordan

Poland

Ghana

Argentina

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

Semcrush Traffic Graph

DNS Record

Host	Type	Class	TTL	Extra
biogen.ca	A	IN	60	Ip: 3.219.125.195
biogen.ca	A	IN	60	Ip: 18.205.8.18
biogen.ca	NS	IN	21600	Target: ns-1057.awsdns-04.org
biogen.ca	NS	IN	21600	Target: ns-1717.awsdns-22.co.uk
biogen.ca	NS	IN	21600	Target: ns-412.awsdns-51.com
biogen.ca	NS	IN	21600	Target: ns-803.awsdns-36.net
biogen.ca	SOA	IN	900	Mname: ns-803.awsdns-36.net Rname: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum-ttl: 86400

Hosting and Whois Zone

IP	3.219.125.195
Domain infomation	Domain Name: biogen.ca Registry Domain ID: D64032-CIRA Registrar WHOIS Server: whois.ca.fury.ca Registrar URL: www.cscglobal.com Updated Date: 2024-02-07T06:05:32Z Creation Date: 2001-02-21T23:36:05Z Registry Expiry Date: 2025-02-21T05:00:00Z Registrar: CSC Corporate Domains (Canada) Company Registrar IANA ID: not applicable Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.3026365400 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Registry Registrant ID: 19921184-CIRA Registrant Name: Biogen Idec MA Inc Registrant Organization: Registrant Street: 14 Cambridge Center Registrant City: Cambridge Registrant State/Province: MA Registrant Postal Code: 02142 Registrant Country: US Registrant Phone: +1.6176792000 Registrant Phone Ext: Registrant Fax: +1.6176792000 Registrant Fax Ext: Registrant Email: [email protected] Registry Admin ID: 19921183-CIRA Admin Name: Brenda Campbell Admin Organization: Biogen Idec Admin Street: 14 Cambridge Center Admin City: Cambridge Admin State/Province: MA Admin Postal Code: 02142 Admin Country: US Admin Phone: +1.6176794384 Admin Phone Ext: Admin Fax: +1.6176794384 Admin Fax Ext: Admin Email: [email protected] Registry Tech ID: 19921506-CIRA Tech Name: Stephen Facciolo Tech Organization: CSC Corporate Domains, Inc. Tech Street: 2711 Centerville Rd. Tech City: Wilmington Tech State/Province: DE Tech Postal Code: 19808 Tech Country: US Tech Phone: +1.3026365400 Tech Phone Ext: Tech Fax: +1.3026365454 Tech Fax Ext: Tech Email: [email protected] Registry Billing ID: Billing Name: Billing Organization: Billing Street: Billing City: Billing State/Province: Billing Postal Code: Billing Country: Billing Phone: Billing Phone Ext: Billing Fax: Billing Fax Ext: Billing Email: Name Server: ns-1057.awsdns-04.org Name Server: ns-1717.awsdns-22.co.uk Name Server: ns-412.awsdns-51.com Name Server: ns-803.awsdns-36.net DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of WHOIS database: 2024-05-01T13:06:39Z <<< For more information on Whois status codes, please visit https://icann.org/epp % % Use of CIRA's WHOIS service is governed by the Terms of Use in its Legal % Notice, available at http://www.cira.ca/legal-notice/?lang=en % % (c) 2024 Canadian Internet Registration Authority, (http://www.cira.ca/)